BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 22083982)

  • 1. Anticancer activity of Nigella sativa (black seed) - a review.
    Randhawa MA; Alghamdi MS
    Am J Chin Med; 2011; 39(6):1075-91. PubMed ID: 22083982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review.
    Gholamnezhad Z; Havakhah S; Boskabady MH
    J Ethnopharmacol; 2016 Aug; 190():372-86. PubMed ID: 27364039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer activities of Nigella sativa (black cumin).
    Khan MA; Chen HC; Tania M; Zhang DZ
    Afr J Tradit Complement Altern Med; 2011; 8(5 Suppl):226-32. PubMed ID: 22754079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on the Cosmeceutical and External Applications of
    Eid AM; Elmarzugi NA; Abu Ayyash LM; Sawafta MN; Daana HI
    J Trop Med; 2017; 2017():7092514. PubMed ID: 29358959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the preclinical pharmacological properties of Nigella sativa (black seeds): a complementary drug with historical and clinical significance.
    Dajani EZ; Shahwan TG; Dajani NE
    J Physiol Pharmacol; 2016 Dec; 67(6):801-817. PubMed ID: 28195061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antifungal activities of the essential oil and various extracts of Nigella sativa and its main component, thymoquinone against pathogenic dermatophyte strains.
    Mahmoudvand H; Sepahvand A; Jahanbakhsh S; Ezatpour B; Ayatollahi Mousavi SA
    J Mycol Med; 2014 Dec; 24(4):e155-61. PubMed ID: 25442918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy.
    Mahmoud YK; Abdelrazek HMA
    Biomed Pharmacother; 2019 Jul; 115():108783. PubMed ID: 31060003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoquinone: A novel strategy to combat cancer: A review.
    Imran M; Rauf A; Khan IA; Shahbaz M; Qaisrani TB; Fatmawati S; Abu-Izneid T; Imran A; Rahman KU; Gondal TA
    Biomed Pharmacother; 2018 Oct; 106():390-402. PubMed ID: 29966985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats.
    Al-Ali A; Alkhawajah AA; Randhawa MA; Shaikh NA
    J Ayub Med Coll Abbottabad; 2008; 20(2):25-7. PubMed ID: 19385451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional Value and Preventive Role of
    Ansary J; Giampieri F; Forbes-Hernandez TY; Regolo L; Quinzi D; Gracia Villar S; Garcia Villena E; Tutusaus Pifarre K; Alvarez-Suarez JM; Battino M; Cianciosi D
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33916916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity of Nigella sativa (black seed) and its relationship with the thermal processing and quinone composition of the seed.
    Agbaria R; Gabarin A; Dahan A; Ben-Shabat S
    Drug Des Devel Ther; 2015; 9():3119-24. PubMed ID: 26124636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Nigella sativa on respiratory, allergic and immunologic disorders, evidence from experimental and clinical studies, a comprehensive and updated review.
    Saadat S; Aslani MR; Ghorani V; Keyhanmanesh R; Boskabady MH
    Phytother Res; 2021 Jun; 35(6):2968-2996. PubMed ID: 33455047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses.
    Marsik P; Kokoska L; Landa P; Nepovim A; Soudek P; Vanek T
    Planta Med; 2005 Aug; 71(8):739-42. PubMed ID: 16142638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on therapeutic potential of Nigella sativa: A miracle herb.
    Ahmad A; Husain A; Mujeeb M; Khan SA; Najmi AK; Siddique NA; Damanhouri ZA; Anwar F
    Asian Pac J Trop Biomed; 2013 May; 3(5):337-52. PubMed ID: 23646296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of primary and specialized metabolites in Nigella sativa seeds, a spice with vast traditional and historical uses.
    Botnick I; Xue W; Bar E; Ibdah M; Schwartz A; Joel DM; Lev E; Fait A; Lewinsohn E
    Molecules; 2012 Aug; 17(9):10159-77. PubMed ID: 22922285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoquinone, an Active Compound of Nigella sativa: Role in Prevention and Treatment of Cancer.
    Almatroodi SA; Almatroudi A; Alsahli MA; Khan AA; Rahmani AH
    Curr Pharm Biotechnol; 2020; 21(11):1028-1041. PubMed ID: 32297580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Nigella sativa (Prophetic Medicine): A Review.
    Ijaz H; Tulain UR; Qureshi J; Danish Z; Musayab S; Akhtar MF; Saleem A; Khan KK; Zaman M; Waheed I; Khan I; Abdel-Daim M
    Pak J Pharm Sci; 2017 Jan; 30(1):229-234. PubMed ID: 28603137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nigella sativa seed extract applicability in preparations against methicillin-resistant Staphylococcus aureus and effects on human dermal fibroblasts viability.
    Gawron G; Krzyczkowski W; Lemke K; Ołdak A; Kadziński L; Banecki B
    J Ethnopharmacol; 2019 Nov; 244():112135. PubMed ID: 31377263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review.
    Majdalawieh AF; Fayyad MW
    Int Immunopharmacol; 2015 Sep; 28(1):295-304. PubMed ID: 26117430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, validation and quantification of thymoquinone in conjunction with assessment of bioactive possessions and GC-MS profiling of pharmaceutically valuable crop Nigella (
    Y R; Periyanadar IV; Saxena SN; Muthurajan R; Sundararajan V; Pridiuldi SV; Meena SS; Naik AN; Harisha CB; Asangi H; Choudhary S; Singh R; Dengeru Y; V KK; Meena NK; Meena RS; Verma AK
    PeerJ; 2024; 12():e17177. PubMed ID: 38563005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.